Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Early vs Delayed Everolimus in Kidney Transplant
NCT00154297Phase 4Completed
- Sponsor
- Novartis
- Start
- Jun 2005
- Primary completion
- Jun 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of everolimus in kidney transplant rejection, sponsored by Novartis. Started Jun 2005; status: completed.
02
Drugs
everolimus
03
Conditions
kidney transplant rejection
Beyond the preview
Go deeper on NCT00154297.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00154297.